Effects of Hirudotherapy, Phytotherapy, and Forest Therapy in Adults With Reduced Work Capacity o… (NCT07709221) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Effects of Hirudotherapy, Phytotherapy, and Forest Therapy in Adults With Reduced Work Capacity or Special Needs
Lithuania100 participantsStarted 2026-04-15
Plain-language summary
This interventional study will evaluate the effects of three complementary and alternative health care services-forest therapy, phytotherapy, and hirudotherapy-in individuals with a participation level below 55% and/or special needs. Participants will be assigned to one of three intervention groups or to a control group. The study will assess changes in blood pressure, body composition, handgrip strength, psychological well-being, perceived stress, and sleep quality before and after the intervention period. Safety, accessibility, feasibility, and acceptability of the services will also be evaluated. The findings will be used to develop standardized and evidence-informed recommendations for providing these services to people with reduced participation and/or special needs.
Who can participate
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
Individuals with a participation level below 55% and/or officially recognized special needs.
Ability and willingness to participate in the study procedures and assigned intervention.
Provision of written informed consent by the participant or, where applicable, by a legally authorized representative.
Ability to complete the planned assessments independently or with reasonable assistance.
Medical condition sufficiently stable to participate in the assigned complementary and alternative health care intervention.
Willingness to attend baseline and post-intervention assessments and the scheduled intervention sessions.
Exclusion Criteria:
Acute illness, fever, active infection, or clinically unstable health condition at the time of enrollment.
Any medical condition that, in the investigator's or intervention provider's judgment, would make participation unsafe.
Known contraindication to the intervention to which the participant may be assigned.
Current participation in another interventional study that could affect the study outcomes.
Inability to provide informed consent and absence of a legally authorized representative.
Inability to comply with the study procedures or intervention schedule despite reasonable accommodations.
Planned major medical procedure or substantial change in treatment during the study period that could influence the study outcomes.
Additional intervention-specific exclusion criteria:
Phytotherapy: known allergy or hypers…
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in Systolic Blood Pressure
Timeframe: Baseline and after completion of the intervention period, approximately 3 months after baseline
2
Change in Diastolic Blood Pressure
Timeframe: Baseline and after completion of the intervention period, approximately 3 months after baseline